DSIP (10mg Vial) Dosage Protocol

DSIP (10 mg Vial) Dosage Protocol

Quickstart Highlights

DSIP dosage protocols can help promote deep, restorative delta-wave sleep and support healthy stress response. Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring nonapeptide (9 amino acids) first isolated from rabbit brain for its ability to enhance slow-wave sleep[1]. Research indicates DSIP may improve sleep quality, normalize sleep architecture, reduce stress-related cortisol patterns, and support mood stabilization without next-day grogginess[2][3]. This educational protocol presents a once-daily subcutaneous evening approach using a practical dilution for clear insulin-syringe measurements.

  • Reconstitute: Add 3.0 mL bacteriostatic water → ~3.33 mg/mL concentration.
  • Typical daily range: 100–300 mcg once daily in the evening (gradual titration).
  • Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg on a U-100 insulin syringe.
  • Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.
DSIP Vial

Dosing & Reconstitution Guide

Educational guide for reconstitution and nightly dosing

Standard / Gradual Approach (3 mL = ~3.33 mg/mL)

Week Daily Dose (mcg) Units (per injection) (mL)
Week 1 100 mcg 3 units (0.03 mL)
Week 2 150 mcg 5 units (0.05 mL)
Week 3 200 mcg 6 units (0.06 mL)
Weeks 4–8 250–300 mcg 8–9 units (0.08–0.09 mL)

Frequency: Inject once daily subcutaneously in the evening, approximately 30–60 minutes before bedtime[4]. For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.

Reconstitution Steps

  1. Draw 3.0 mL bacteriostatic water with a sterile syringe.
  2. Inject slowly down the vial wall; avoid foaming.
  3. Gently swirl/roll until dissolved (do not shake).
  4. Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Supplies Needed

Plan based on an 8–12 week nightly protocol with gradual titration.

  • Peptide Vials (DSIP, 10 mg each):

    • 8 weeks ≈ 1 vial (10 mg supports ~33–100 doses at 100–300 mcg)
    • 12 weeks ≈ 2 vials
  • Insulin Syringes (30- or 50-unit recommended for small volumes):

    • Per week: 7 syringes (1/day)
    • 8 weeks: 56 syringes
    • 12 weeks: 84 syringes
  • Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.

    • 8 weeks (1 vial): 3 mL → 1 × 10 mL bottle
    • 12 weeks (2 vials): 6 mL → 1 × 10 mL bottle
  • Alcohol Swabs: One for the vial stopper + one for the injection site each day.

    • Per week: 14 swabs (2/day)
    • 8 weeks: 112 swabs → recommend 2 × 100-count boxes
    • 12 weeks: 168 swabs → recommend 2 × 100-count boxes
DSIP Vial
View Supplier
Insulin Syringes
View Supplier
Bacteriostatic Water
View Supplier
Alcohol Pads
View Supplier

Protocol Overview

Concise summary of the once-daily evening regimen.

  • Goal: Support improved sleep quality, enhanced delta-wave (slow-wave) sleep, and stress modulation over time[2][3].
  • Schedule: Daily subcutaneous injections in the evening for 8–12 weeks.
  • Dose Range: 100–300 mcg daily with gradual titration.
  • Reconstitution: 3.0 mL per 10 mg vial (~3.33 mg/mL) for accurate unit measurements.
  • Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.

Dosing Protocol

Suggested nightly titration approach.

  • Start: 100 mcg nightly; increase by ~50 mcg every 1–2 weeks as tolerated.
  • Target: 250–300 mcg nightly by Weeks 4–8.
  • Frequency: Once per day (subcutaneous), 30–60 minutes before bedtime.
  • Cycle Length: 8–12 weeks; consider a break after the cycle.
  • Timing: Evening dosing to align with natural sleep onset; rotate injection sites.

Storage Instructions

Proper storage preserves peptide quality.

  • Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure[5].
  • Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); prepare aliquots if needed and avoid freeze–thaw.
  • Allow vials to reach room temperature before opening to reduce condensation uptake.

Important Notes

Practical considerations for consistency and safety.

  • Use new sterile insulin syringes; dispose in a sharps container.
  • Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation[6].
  • Inject slowly; wait a few seconds before withdrawing the needle.
  • Document daily dose and site rotation to maintain consistency.
  • Avoid other sedatives during DSIP use to clearly evaluate its effects on sleep.

How This Works

DSIP acts as a neuromodulator of the sleep-wake cycle and stress response. Administration consistently increases delta-wave (slow-wave) sleep in EEG recordings[2], suggesting it promotes the initiation and maintenance of deep, non-REM sleep. DSIP readily crosses the blood-brain barrier to exert central effects[7] and may enhance inhibitory neuronal activity or modulate sleep-regulating brain regions. Additionally, DSIP attenuates ACTH and corticosterone release in response to stress, indicating an effect on the hypothalamic-pituitary-adrenal axis[8]. Unlike conventional sedatives, DSIP tends to normalize sleep architecture without next-day grogginess[3].

Potential Benefits & Side Effects

Observations from preclinical and clinical literature.

  • Supports improved sleep quality and increased slow-wave (delta) sleep duration[2][3].
  • May help normalize disrupted sleep patterns in chronic insomnia[3].
  • Shows potential for stress reduction and mood support through HPA axis modulation[8][9].
  • Remarkably safe profile: animal studies found no lethal dose even at extremely high doses; human studies report only mild, transient side effects (occasional headache or nausea)[1][8].
  • Occasional mild injection-site reactions (redness/itch) may occur with subcutaneous administration.

Lifestyle Factors

Complementary strategies for best outcomes.

  • Maintain consistent sleep-wake schedules to reinforce circadian rhythm.
  • Limit caffeine and screen exposure in the evening hours.
  • Create a dark, cool sleep environment to support natural melatonin production.
  • Prioritize stress management techniques and regular physical activity during daytime hours.

Injection Technique

General subcutaneous guidance from clinical best-practice resources[6][10].

  • Clean the vial stopper and skin with alcohol; allow to dry.
  • Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue[6].
  • Do not aspirate for subcutaneous injections; inject slowly and steadily.
  • Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy[10].
  • Using a 30- or 50-unit insulin syringe improves accuracy when measuring small volumes (3–9 units).

Important Note

This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment.

References


  • European Journal of Anaesthesiology
    — Delta sleep-inducing peptide: discovery, structure, and pharmacological overview
    View Source

  • Neuroscience & Biobehavioral Reviews (PubMed)
    — Delta-sleep-inducing peptide (DSIP): a review of sleep-promoting and neuromodulatory effects
    View Source

  • European Neurology (PubMed)
    — Effects of delta-sleep-inducing peptide on 24-hour sleep-wake behaviour in severe chronic insomnia
    View Source

  • European Neurology (PubMed)
    — DSIP in insomnia: timing and frequency of administration in clinical trials
    View Source

  • Tocris Bioscience
    — Stability and storage guidelines for research peptides
    View Source

  • MedlinePlus (U.S. National Library of Medicine)
    — Subcutaneous (SQ) injections: technique, site selection, and procedure
    View Source

  • Frontiers in Pharmacology
    — DSIP fusion peptides crossing the blood-brain barrier and efficacy in insomnia models
    View Source

  • European Neurology (PubMed)
    — Therapeutic effects of delta-sleep-inducing peptide (DSIP) in patients with chronic pain episodes
    View Source

  • European Neurology (PubMed)
    — DSIP in the treatment of withdrawal syndromes from alcohol and opiates
    View Source

  • Johns Hopkins Arthritis Center
    — How to give a subcutaneous injection: site rotation and best practices
    View Source

  • European Neurology (PubMed)
    — Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients (double-blind study)
    View Source

  • CDC
    — Vaccine administration: subcutaneous route (angle/site guidance)
    View Source

  • NCBI Bookshelf
    — Best practices for injection (asepsis, preparation, and administration)
    View Source

  • Subcutaneous Drug Injection Review (PMC)
    — Pharmacologic considerations of the subcutaneous route
    View Source

  • Pure Lab Peptides
    — DSIP (10 mg) product page (quality and batch documentation)
    View Source